DCBO
Docebo Inc.
DCBO has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over DCBO overall, supported by stronger modeled upside and stronger fundamentals.
DCBO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
DCBO's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
DCBO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $32.48 | — |
| Cheap | 23x | $26.30 | -19% |
| Current | 28x | $32.48 | — |
| Fair | 75x | $86.97 | +168% |
| Expensive | 222x | $257 | +692% |
Historical ranges are pointers, not guarantees.
DCBO's PE is in its cheap range at 28x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over DCBO in the historical PE scenario, which offers more potential upside but is not a forecast.
DCBO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for DCBO, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
DCBO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.71 | +47% |
| Q2 2026 | $1.16 | +68% |
| Q1 2026 | $1.18 | +59% |
| Q4 2025 | $1.29 | +50% |
| Q3 2025 | $0.74 | +30% |
| Q2 2025 | $0.69 | +30% |
| Q1 2025 | $0.74 | +252% |
| Q4 2024 | $0.86 | +975% |
| Q3 2024 | $0.57 | +1040% |
DCBO's earnings per share have climbed steadily: $1.16 over the past year, up 68% from the year before, and higher year over year for nine quarters in a row.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over DCBO in the latest year-over-year earnings comparison.
DCBO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $68.7M | +13% |
| Q1 2026 | $65.6M | +15% |
| Q4 2025 | $63M | +11% |
| Q3 2025 | $61.6M | +11% |
| Q2 2025 | $60.7M | +14% |
| Q1 2025 | $57.3M | +11% |
| Q4 2024 | $57M | +16% |
| Q3 2024 | $55.4M | +19% |
DCBO's revenue has grown year over year every quarter since late 2020: $69M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.1% | -1.3 points |
| Q1 2026 | -0.1% | -3 points |
| Q4 2025 | 15% | +1.2 points |
| Q3 2025 | 13% | +4.7 points |
| Q2 2025 | 8.4% | -0.2 points |
| Q1 2025 | 3% | -5.2 points |
| Q4 2024 | 14% | +12 points |
| Q3 2024 | 8.5% | +1.8 points |
DCBO's operating margin was 7.1% last quarter, down 1.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over DCBO on profitability, with a higher operating margin.
DCBO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.2M | -154% |
| Q1 2026 | $24M | +214% |
| Q4 2025 | $8.6M | -9.3% |
| Q3 2025 | $5.1M | +31% |
| Q2 2025 | $6M | -8% |
| Q1 2025 | $7.6M | -7% |
| Q4 2024 | $9.4M | +52% |
| Q3 2024 | $3.9M | -37% |
DCBO usually generates cash, though not every quarter: the latest was −$3M, but it generated $34M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over DCBO on cash flow, with more consistent year-over-year improvement.
DCBO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -1.3M shares |
| 1 year | -11% | -3.4M shares |
| 3 years | -19% | -6.4M shares |
| 5 years | -18% | -6M shares |
| Available history | -5.8% | -1.7M shares |
DCBO has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $16.3M |
| Q1 2026 | $62.2M |
| Q4 2025 | $6,909 |
| Q3 2025 | $3.4M |
| Q2 2025 | $34.2M |
| Q4 2024 | $238,000 |
| Q3 2024 | $5.9M |
| Q2 2024 | $5.1M |
DCBO spent $82M buying back its own shares over the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
DCBO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | -2.6x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -2.8x | Net Cash |
| Q3 2024 | -4.2x | Net Cash |
| Q2 2024 | -4.7x | Net Cash |
DCBO's net debt is about 2.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over DCBO on leverage, with a lower net debt burden relative to earnings.
DCBO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.1 | Overbought |
| Stochastic | 85.1 | Overbought |
DCBO's weekly RSI is 72 (overbought) and its Stochastic is 85 (overbought).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
DCBO PE vs Technology Sector
| Metric | DCBO | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 28x | 0.3% above |
| PE % | 22 | 39 | 17 pts below |
DCBO is trading at 28x earnings, in line with the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over DCBO on valuation relative to its sector.
DCBO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.7 | 17% above |
| 20 week MA | $24.3 | 34% above |
| 50 week MA | $21.1 | 54% above |
| 100 week MA | $26.2 | 24% above |
| 200 week MA | $34.0 | 4.5% below |
DCBO has stronger trend alignment. DCBO is above 4 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
DCBO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.1 | $57.7 | +15% |
| 2021 | $57.7 | $68.1 | +18% |
| 2022 | $68.1 | $31.9 | -53% |
| 2023 | $31.9 | $48.4 | +51% |
| 2024 | $48.4 | $45.7 | -5.6% |
| 2025 | $45.7 | $22.2 | -51% |
| 2026 YTD | $22.2 | $32.5 | +46% |
DCBO is up 46% so far in 2026, after finishing lower in three of the previous six years.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over DCBO on returns for 2026, with the stronger performance.